← SynDRA
METHYLDOPA
SynDRA canonical compound SYN0000260 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | DDC |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- ADRA2A
- DDC
- ADRA2B
- ADRA2C
- ALOX15
- DRD2
- EGFR
- FYN
- KDM4E
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRA2A AGONIST
- Adrenergic receptor alpha-2 agonist
- ADRA2C AGONIST
- ADRA2B AGONIST
- DRD2 AGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- C02A · ANTIADRENERGIC AGENTS, CENTRALLY ACTING
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- methyldopa (levorotatory)
- aldochlor
- aldomine
- alphamethyldopa
- lederdopa
- (-)-alpha-Methyl-3,4-dihydroxyphenylalanine
- Methyldopa (levorotatory)
- Metildopa
- Methyldopa hydrate
- Methyldopa sesquihydrate
- (-)-.alpha.-methyldopa
- (s)-(-)-.alpha.-methyldopa
- .alpha.-methyl-l-dopa
- Alpha-methyldopa
- Anhydrous methyldopa
- L-.alpha.-methyldopa
- Methyldopa anhydrous
- Methyldopa, anhydrous
- BAYER-1440L
- J9.247I
- MK-351
- NSC-169916
- NSC-760080
- Aldomet
- Dopamet
- Dopegyt
- Lederdopa
- Medomet
- Medopren
- Metalpha 250
- Metalpha 500
- Methyldopa component of aldoril
- Presinol
- AMD
- Aldometil
- Aldomin
- Alphamethyldopa
- Baypresol
Reported adverse events
- Parkinsonism
- Sedation
- Headache
- Hypersensitivity
- Toxic epidermal necrolysis
- Arthralgia
- Myocarditis
- Pancreatitis
- Bell's palsy
Look up METHYLDOPA in the interactive SynDRA portal →